Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 10, Issue Suppl 2
1137 SuperNova1 (SNV1), a novel oncolytic-cell based platform for cancer therapy
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1137 SuperNova1 (SNV1), a novel oncolytic-cell based platform for cancer therapy
Free
Online download statistics by month:
Online download statistics by month: November 2022 to October 2024
Abstract
Full
Pdf
Nov 2022
152
0
16
Dec 2022
42
0
4
Jan 2023
66
0
5
Feb 2023
52
0
4
Mar 2023
18
0
3
Apr 2023
26
0
0
May 2023
42
0
4
Jun 2023
36
0
4
Jul 2023
34
0
4
Aug 2023
34
0
3
Sep 2023
38
0
4
Oct 2023
72
0
4
Nov 2023
42
0
3
Dec 2023
34
0
2
Jan 2024
44
0
3
Feb 2024
18
0
1
Mar 2024
54
0
2
Apr 2024
40
0
4
May 2024
30
0
1
Jun 2024
24
0
4
Jul 2024
38
0
2
Aug 2024
28
0
7
Sep 2024
40
0
5
Oct 2024
30
0
10
Total
1034
0
99
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?